Karyopharm grants 1,850 RSUs to two newly hired employees
Karyopharm Therapeutics Inc. announced it granted an aggregate of 1,850 restricted stock units (RSUs) to two newly-hired employees under Nasdaq Listing Rule 5635(c)(4).
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.